Global Single-Use Bioprocessing Market was valued at US$ xx Mn in 2019 and is expected to reach US$ xx Mn by 2026, at a CAGR of 17.1%.
Global Single-Use Bioprocessing Market Introduction

For the development and manufacturing of pharmaceutical products such as vaccines, monoclonal antibodies (mAbs), personalized medicine, and others, single-use bioprocessing uses disposable technologies. During the development stages of drugs and the manufacturing of several biopharmaceuticals, the use of single-use bioprocessing products has increased significantly. This product has revolutionized both the upstream and downstream processes of drug manufacturing, making them faster, easier, and less expensive.
Global Single-Use Bioprocessing Market Dynamics

Single-Use Technology (SUT) has proliferated the use of disposables in the bioprocessing industry due to the benefits it provides, such as a significant reduction in capital cost and facility construction time. As a result, the market for single-use bioprocessing has grown by double digits. Furthermore, despite the global economic losses caused by the COVID-19 pandemic, the market grew significantly.

Several CMOs and bio manufacturers have shifted their focus to the development of SARS-CoV-2 infection therapeutics using disposable technologies. Serum Institute chose ABEC's Custom Single Run (CSR) technology in September 2020 to speed up large-scale, single-use manufacturing of nearly 1.0 billion doses of Novavax vaccine against COVID-19.

Besides, increasing demand for biopharmaceuticals, faster implementation and lower risk of product cross-contamination, and lower costs and lower environmental impact of single-use bioprocessing technologies are some of the factors driving the single-use bioprocessing market. Single-use technology is a well-known manufacturing scale technology that is widely used in upstream pre-commercial biopharmaceutical manufacturing.

The high adoption of these devices is due to their speed and flexibility while keeping total operating costs low. High energy efficiency, fewer space requirements, low water usage, and a lower risk of contamination are some of the other factors driving the market's revenue growth. In addition, automation in the single-use system prompted the incorporation of big data-based machine learning, which is expected to aid in increasing product yield. In addition to the ability to achieve maximum productivity and efficiency in terms of process, the single-use bioprocessing market is being fueled by a mainstream approach by many biopharmaceutical manufacturers.

Over the forecast period, the growing number of biological approvals and patent expirations are expected to increase the biopharmaceuticals manufacturing process, resulting in an increase in the use of single-use bioprocessing. In addition, in recent years, there has been a significant increase in the number of partnerships between industries and academic institutions which is expected to increase demand for single-use bioprocessing.
Global Single-Use Bioprocessing Market Segment Analysis

The biopharmaceutical manufacturers segment dominated the single-use bioprocessing market in 2020, accounting for more than 58.0 % of revenue. The pharmaceutical supply chain has been impacted by the COVID-19 pandemic. Many products sold in countries like the United States, Europe, and other countries were impacted by the restrictions on pharmaceutical manufacturing and export.

In the midst of the COVID-19 pandemic, countries' health systems are investing heavily in research and development to combat the virus. To screen SARS-CoV-2 against a library of 50,000 compounds, a single-use bioreactor is required for flexibility and speed while keeping total operating costs to a bare minimum. The government has outlined detailed guidelines for institutions to share biospecimens and data for such studies.

In addition, ABEC Inc. launched a single-use bioreactor system with a working volume of 6,000 L in September 2019, which is three times the industry's standard upper limit. During the COVID-19, single-use bioprocessing is critical, resulting in several growth opportunities.

Increasing clinical research activities to better understand the potential of biotherapeutics in various disease areas is expected to boost the single-use bioprocessing market. The presence of institutes like the National Institute for Bioprocessing Research and Training, which provides training and research expertise for the bioprocessing industry, is also boosting the segment growth.

Global Single-Use Bioprocessing Market

To know about the Research Methodology :- Request Free Sample Report
Global Single-Use Bioprocessing Market Regional Insights

Global Single-Use Bioprocessing Market 1

With a revenue share of 33.5% in 2020, North America dominated the single-use bioprocessing market. The region's dominance has been aided by the rising biopharmaceutical R&D and the presence of large-scale biopharmaceutical manufacturing facilities in the United States. Furthermore, the North American region is home to a large number of contract manufacturing companies that are integrating disposables into their workflows.

The investments in this market space have accelerated as a result of this growing trend. Fujifilm Diosynth, for example, spent USD 2 billion in January 2021 on a large cell culture production facility in the United States. There are expected to be eight 20,000-liter bioreactors at this location. With the growing biopharmaceutical manufacturing industry, China has emerged as a potential market for single-use technology in recent years.

Furthermore, the North American government is investing heavily in the development of COVID-19 vaccines, drugs, and diagnostic tests, which is expected to drive demand for single-use bioreactors and, as a result, overall market growth.

In addition, The Canadian government announced CAD 275 million (EUR 179 million) in R&D funding for COVID-19 antivirals, diagnostics, vaccines, and clinical trials in March 2020. Furthermore, in April 2020, the United States government awarded Moderna Inc. USD 483 million for the development of a COVID-19 vaccine.

For more information visit : https://www.maximizemarketresearch.com/market-report/global-single-use-bioprocessing-market/105384/

Global Single-Use Bioprocessing Market Report Scope: Inquire before buying

Global Single-Use Bioprocessing Market 2
Global Single-Use Bioprocessing Market, by Region

• North America
• Europe
• South America
• MEA
• Asia Pacific
Global Single-Use Bioprocessing Market Key Players

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Sartorius AG
• Corning Incorporated
• Pall Corporation
• General Electric Company (GE Healthcare)
• Eppendorf AG
• Rentschler Biopharma SE
• Lonza
• Meissner Filtration Products, Inc.
• JM BioConnect
• Boehringer Ingelheim GmbH
• Infors AG
• PBS Biotech, Inc.
• Entegris, Inc.
• Danaher Corporation
• Kuhner AG
• Rentschler Biopharma SE

This Report Is Submitted By : Maximize Market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your

demand. This report can be personalized to meet your requirements. Get in

touch with us and our sales team will guarantee provide you to get a report that

suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high

growth emerging opportunities & technologies as well as threats to the

companies across the Healthcare, Pharmaceuticals, Electronics &

Communications, Internet of Things, Food and Beverages, Aerospace and

Defense and other manufacturing sectors.